Atlas Trials

The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients

Clinical trial NCT04525313 · UNKNOWN

Trial details

NCT number
NCT04525313
Sponsor
Fudan University
Status
UNKNOWN
Study type
OBSERVATIONAL
Colorectal CancerLiver Metastases
Start date
2020-08-01
Primary completion
2022-12-01
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.